These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
291 related items for PubMed ID: 9804775
21. Characterization of a folate transporter in HeLa cells with a low pH optimum and high affinity for pemetrexed distinct from the reduced folate carrier. Wang Y, Zhao R, Goldman ID. Clin Cancer Res; 2004 Sep 15; 10(18 Pt 1):6256-64. PubMed ID: 15448015 [Abstract] [Full Text] [Related]
22. Patterns of cross-resistance to the antifolate drugs trimetrexate, metoprine, homofolate, and CB3717 in human lymphoma and osteosarcoma cells resistant to methotrexate. Diddens H, Niethammer D, Jackson RC. Cancer Res; 1983 Nov 15; 43(11):5286-92. PubMed ID: 6225514 [Abstract] [Full Text] [Related]
32. A reduced folate carrier mutation produces substrate-dependent alterations in carrier mobility in murine leukemia cells and methotrexate resistance with conservation of growth in 5-formyltetrahydrofolate. Zhao R, Assaraf YG, Goldman ID. J Biol Chem; 1998 Apr 03; 273(14):7873-9. PubMed ID: 9525881 [Abstract] [Full Text] [Related]
33. Molecular events in the membrane transport of methotrexate in human CCRF-CEM leukemia cell lines. Freisheim JH, Ratnam M, McAlinden TP, Prasad KM, Williams FE, Westerhof GR, Schornagel JH, Jansen G. Adv Enzyme Regul; 1992 Apr 03; 32():17-31. PubMed ID: 1323203 [Abstract] [Full Text] [Related]
35. Loss of multidrug resistance protein 1 expression and folate efflux activity results in a highly concentrative folate transport in human leukemia cells. Assaraf YG, Rothem L, Hooijberg JH, Stark M, Ifergan I, Kathmann I, Dijkmans BA, Peters GJ, Jansen G. J Biol Chem; 2003 Feb 28; 278(9):6680-6. PubMed ID: 12486126 [Abstract] [Full Text] [Related]
36. 5-amino-4-imidazolecarboxamide riboside potentiates both transport of reduced folates and antifolates by the human reduced folate carrier and their subsequent metabolism. McGuire JJ, Haile WH, Yeh CC. Cancer Res; 2006 Apr 01; 66(7):3836-44. PubMed ID: 16585211 [Abstract] [Full Text] [Related]
37. Efficient utilization of the reduced folate carrier in CCRF-CEM human leukemic lymphoblasts by the potent antifolate N(alpha)-(4-amino-4-deoxypteroyl)-N(delta)-hemiphthaloyl-L- ornithine (PT523) and its B-ring analogues. Wright JE, Vaidya CM, Chen Y, Rosowsky A. Biochem Pharmacol; 2000 Jul 01; 60(1):41-6. PubMed ID: 10807943 [Abstract] [Full Text] [Related]